Starting from September 15th, the prices of six major categories of medical consumables will begin to decrease!
# Shandong Province: Medical consumables price reduction policy is fully launched
On September 8, the Shandong Provincial MPA issued the Notice on the Implementation of the Third Batch of Medical Consumables in Shandong Province and the Results of the Inter-provincial Alliance Joint Bone Cement Medical Consumables Centralized Procurement.
Scope of implementation:
- Public medical institutions in the province
- Social medical institutions designated by medical security healthcaire
procurement cycle
- The procurement cycle is 2 years
- The purchase and sale agreement is signed every year
The implementation of this policy will greatly reduce the medical burden of patients and enable more people to access high-quality medical services.
💡 Key data
- The average price reduction of centralized procurement is 83.13%
- According to the agreed purchase volume, the related costs can be reduced by 853 million yuan per year
This will allow more patients to benefit from lower prices and more reasonable and manageable healthcare costs.
#Gansu Province: Comprehensive procurement of medical consumables in bulk
Not only Shandong, Gansu has also joined the ranks of medical supplies price reduction. In the Notice on the implementation of the selection results of the centralized Procurement of four categories of medical consumables such as joint bone cement released on September 7, it is clear that since September 15, 2023, the province will implement the selection results of four categories of medical consumables.
Varieties involved:
- Joint bone cement
- Coronary dilating balloon
- Cardiac pacemaker
- Liver function biochemical test reagent
Scope of implementation:
- All public health institutions
- Social medical institutions designated by medical security healthcare.
procurement cycle
- The procurement cycle of coronary dilation balloon is 3 years
- The purchase cycle of other varieties is 2 years
📉 The price cut is amazing!
- In the centralized procurement of joint bone cement consumables in the Beijing Tianjin Hebei “3+N” alliance, the price has been reduced by up to 83.13%, and the related costs can be reduced by 853 million yuan per year, accounting for 95% of the total demand in the alliance region..
- The average price reduction of coronary dilation balloons is 90.72%, and the price reduction of imported products is 88.97%. This means that the price of a coronary expansion balloon in the League area has dropped from an average of 3,401 yuan to just 319 yuan！
- Pacemaker volume purchase results show that the price of whole-body compatible MRI pacemakers all fell below 20,000 yuan, while the price of non-compatible MRI pacemakers also dropped significantly, to a minimum of 12,895.96 yuan.
- In the centralized procurement of biochemical detection reagents for liver function in the inter-provincial alliance, the average reduction of selected products is 68.64%, and the reduction of low-density lipoprotein is as high as 95.64%, which can save 2 billion yuan for the alliance
- Although the specific reduction of ultrasonic knife and stapler consumables has not been announced, through the volume linkage method, the product price is reduced and a more favorable market environment is created.
# More convenient way to settle accounts
In the implementation document, Shandong and Gansu have stressed the timely settlement of the purchase price of selected consumables to ensure that patients can enjoy more convenient medical services.
Shandong Province implements direct settlement of medical security healthcare, and the payment for selected products is included in the direct settlement scope in time.
Gansu Province requires medical institutions and enterprises to settle the payment in time, and the settlement time shall not exceed the end of the month from the date of use of consumables.
This series of settlement policies will greatly reduce the financial pressure on medical institutions and will also promote medical device companies to further improve product quality and competitiveness. We look forward to seeing more provinces also adopt similar policies to ensure the smooth flow of supply chains and funds for medical institutions and promote the sustainable development of the medical device industry.
China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com
Source：Article source: Device market
Translated & edited ： Bradyknow
